Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1234, 2000-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
COX-2 inhibition has potential for lung cancer prevention
Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. :
HER2 predicts response to an anthracycline-containing regimen
Inpharma, Vol. 1, Iss. 1539, 2006-01 ,pp. :
Efavirenz-containing regimen superior in advanced HIV
Inpharma, Vol. 1, Iss. 1331, 2002-01 ,pp. :